MetaCap

BioNexus Gene Lab Corp (BGLC)

NASDAQ: BGLCHealth CareMedical SpecialitiesUSD

1.34+0.085 (+6.77%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

BGLC stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.26
52-week range
1.07 – 5.89
Day range
1.21 – 1.36
Volume / Avg
26.63K / 10.82K
Beta
—

52-week range

$1.07$5.89

BGLC stock today

Shares of BioNexus Gene Lab (BGLC) finished higher on Oct 7 at $1.34, a gain of 6.77% or $0.085 per share, versus the S&P 500's 0.22% decline. Volume was 2.5x the average at 26.63K shares, a sign of unusually heavy trading. At this level, BGLC sits near the bottom of its 52-week range of $1.07 to $5.89: 77.2% below the high and 25.2% above the low.

BioNexus Gene Lab has posted a net loss over the last twelve months (EPS of -$1.26), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About BioNexus Gene Lab

Company profile
Industry
Medical Specialities

BioNexus Gene Lab peers

Health Care sector
BGLC peer companies
CompanyPrice% ChgMarket capCompare
ACONAclarion Inc.2.35+2.40%$6.77Mvs BGLC
AMSAmerican Shared Hospital Services1.35-2.17%$8.98Mvs BGLC
ADVBAdvanced Biomed Inc.6.21-2.66%$10.26Mvs BGLC
ACHAccendra Health Inc.0.4729+1.46%$36.37Mvs BGLC
MDXHMDxHealth SA0.5998-0.02%$57.23Mvs BGLC
SERASera Prognostics Inc. Class A2.07+0.98%$81.66Mvs BGLC
KEQUKewaunee Scientific Corporation33.84+0.53%$97.98Mvs BGLC
PSNLPersonalis Inc.16.00-0.19%$1.71Bvs BGLC

Indexes, lists and sector

BioNexus Gene Lab stock FAQ

What is BioNexus Gene Lab's stock price today?

BGLC last traded at $1.34 as of Oct 7, 4:00 PM EDT, up 6.77% on the day. Prices are delayed at least 15 minutes.

What is the BGLC 52-week high?

The 52-week high for BGLC is $5.89 and the 52-week low is $1.07. The stock is currently 77.2% below its high.

Compare BGLC